Clinical Trial Update: Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 study update on fedovapagon for nocturia in men with benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Nocturia

Drugs mentioned

• Fedovapagon

Snippet

Sponsor: Vantia Ltd | Conditions: Nocturia | Phase 2, Phase 3 | Status: COMPLETED